Canoga Park, CALIFORNIA9 Active Studies

Ankylosing Spondylitis Clinical Trials in Canoga Park, CALIFORNIA

Find 9 actively recruiting ankylosing spondylitis clinical trials in Canoga Park, CALIFORNIA. Connect with local research sites and explore new treatment options.

9
Active Trials
7
Sponsors
11,002
Enrolling

Recruiting Ankylosing Spondylitis Studies in Canoga Park

RecruitingCanoga Park, CALIFORNIANCT06742723

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

International, Multicenter, Double-Blind, Placebo-Controlled and Event-driven study to assess efficacy, safety and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and ca...

5,000 participants
AstraZeneca
View Study Details
RecruitingCanoga Park, CALIFORNIANCT06632444

LIVERAGEā„¢: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

This study is open to adults who are at least 18 years old living with obesity and have: * a confirmed liver disease called non-alcoholic steatohepatitis (NASH)/metabolic associated steatohepatitis (...

1,800 participants
Boehringer Ingelheim
View Study Details
RecruitingCanoga Park, CALIFORNIANCT06632457

LIVERAGEā„¢ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

This study is open to adults who are at least 18 years old and have: * A confirmed liver disease called non-alcoholic steatohepatitis (NASH) or * A confirmed liver disease called metabolic-associated...

1,590 participants
Boehringer Ingelheim
View Study Details
RecruitingCanoga Park, CALIFORNIANCT06318169

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

The study will assess the efficacy and safety of 2 dose regimens of pegozafermin for the treatment of liver fibrosis stage 2 or 3 in adult participants with MASH (previously known as nonalcoholic stea...

1,050 participants
89bio, Inc.
View Study Details
RecruitingCanoga Park, CALIFORNIANCT06709014

A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

The goal of this clinical trial is to learn if buntanetap/Posiphen works to treat early Alzheimer's disease in adults aged 55-85. It will also learn about the safety of buntanetap/Posiphen. The main q...

760 participants
Annovis Bio Inc.
View Study Details
RecruitingCanoga Park, CALIFORNIANCT06899217

A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.

The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help to decrease nausea severity associated with idiopathic gastroparesis severity in adult subjects. The...

400 participants
CinDome Pharma, Inc.
View Study Details
RecruitingCanoga Park, CALIFORNIANCT06625398

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)

This is a clinical trial assessing the efficacy, safety, and tolerability of an investigational drug, VRDN-003, in participants with chronic Thyroid Eye Disease (TED)....

195 participants
Viridian Therapeutics, Inc.
View Study Details
RecruitingCanoga Park, CALIFORNIANCT06625411

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)

This is a clinical trial assessing the efficacy, safety, and tolerability of an investigational drug, VRDN-003, in participants with active Thyroid Eye Disease (TED)....

117 participants
Viridian Therapeutics, Inc.
View Study Details
RecruitingCanoga Park, CALIFORNIANCT05519475

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

This study is researching an investigational drug, ALN-HSD called "study drug". This study is focused on participants who are known to have metabolic dysfunction-associated steatohepatitis (MASH). MAS...

90 participants
Regeneron Pharmaceuticals
View Study Details

About Ankylosing Spondylitis Clinical Trials in Canoga Park

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 9 ankylosing spondylitis clinical trials recruiting participants in Canoga Park, CALIFORNIA. These studies are seeking a combined 11,002 participants. Research is being sponsored by AstraZeneca, Boehringer Ingelheim, 89bio, Inc. and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Canoga Park — FAQ

Are there ankylosing spondylitis clinical trials in Canoga Park?

Yes, there are 9 ankylosing spondylitis clinical trials currently recruiting in Canoga Park, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Canoga Park?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Canoga Park research site will contact you about next steps.

Are clinical trials in Canoga Park free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Canoga Park studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 9 active trials in Canoga Park are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov